title: A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection.
authors.affiliation: Southern California Liver Centers, Coronado, CA, USA. Electronic address: thassanein@livercenters.com.
authors.forename: Tarek
authors.initials: T
authors.lastname: Hassanein
authors.affiliation: Bristol-Myers Squibb, Hopewell, NJ, USA.
authors.forename: Karen D
authors.initials: KD
authors.lastname: Sims
authors.affiliation: Medical Associates Research Group, San Diego, CA, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Bennett
authors.affiliation: Atlanta Gastroenterology Associates, Atlanta, GA, USA.
authors.forename: Norman
authors.initials: N
authors.lastname: Gitlin
authors.affiliation: The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX, USA.
authors.forename: Eric
authors.initials: E
authors.lastname: Lawitz
authors.affiliation: Research and Education Inc, San Diego, CA, USA.
authors.forename: Tuan
authors.initials: T
authors.lastname: Nguyen
authors.affiliation: CRI Lifetree, Salt Lake City, UT, USA.
authors.forename: Lynn
authors.initials: L
authors.lastname: Webster
authors.affiliation: Inova Fairfax Hospital, Center for Liver Diseases, Falls Church, VA, USA.
authors.forename: Zobair
authors.initials: Z
authors.lastname: Younossi
authors.affiliation: Miami Research Associates, South Miami, FL, USA.
authors.forename: Howard
authors.initials: H
authors.lastname: Schwartz
authors.affiliation: Mercy Medical Center, Baltimore, MD, USA.
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Thuluvath
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Helen
authors.initials: H
authors.lastname: Zhou
authors.affiliation: Bristol-Myers Squibb, Hopewell, NJ, USA.
authors.forename: Bhaskar
authors.initials: B
authors.lastname: Rege
authors.affiliation: Bristol-Myers Squibb, Wallingford, CT, USA.
authors.forename: Fiona
authors.initials: F
authors.lastname: McPhee
authors.affiliation: Bristol-Myers Squibb, Wallingford, CT, USA.
authors.forename: Nannan
authors.initials: N
authors.lastname: Zhou
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Megan
authors.initials: M
authors.lastname: Wind-Rotolo
authors.affiliation: Bristol-Myers Squibb, Hopewell, NJ, USA.
authors.forename: Ellen
authors.initials: E
authors.lastname: Chung
authors.affiliation: Bristol-Myers Squibb, Hopewell, NJ, USA.
authors.forename: Amber
authors.initials: A
authors.lastname: Griffies
authors.affiliation: Bristol-Myers Squibb, Hopewell, NJ, USA.
authors.forename: Dennis M
authors.initials: DM
authors.lastname: Grasela
authors.affiliation: Bristol-Myers Squibb, Hopewell, NJ, USA.
authors.forename: David F
authors.initials: DF
authors.lastname: Gardiner
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects; D001552:Benzazepines / Q000008:administration & dosage / Q000009:adverse effects; D002219:Carbamates; D016903:Drug Monitoring; D024882:Drug Resistance, Viral; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000821:virology; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects; D007546:Isoquinolines / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011759:Pyrrolidines; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome; D014633:Valine / Q000031:analogs & derivatives
chemical_list: C587012:8-cyclohexyl-N-((dimethylamino)sulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)cycloprop(d)indolo(2,1-a)(2)benzazepine-5-carboxamide; D000998:Antiviral Agents; D001552:Benzazepines; D002219:Carbamates; D004791:Enzyme Inhibitors; D007093:Imidazoles; D007211:Indoles; D007546:Isoquinolines; D011759:Pyrrolidines; D013449:Sulfonamides; D014633:Valine; C549273:daclatasvir; C571889:asunaprevir